219 related articles for article (PubMed ID: 31210774)
1. Identify the Key Active Ingredients and Pharmacological Mechanisms of Compound XiongShao Capsule in Treating Diabetic Peripheral Neuropathy by Network Pharmacology Approach.
Yu M; Song X; Yang W; Li Z; Ma X; Hao C
Evid Based Complement Alternat Med; 2019; 2019():5801591. PubMed ID: 31210774
[TBL] [Abstract][Full Text] [Related]
2. Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.
Lin Y; Shen C; Wang F; Fang Z; Shen G
J Diabetes Res; 2021; 2021():9941791. PubMed ID: 34159207
[TBL] [Abstract][Full Text] [Related]
3. Compound XiongShao Capsule ameliorates streptozotocin-induced diabetic peripheral neuropathy in rats via inhibiting apoptosis, oxidative - nitrosative stress and advanced glycation end products.
Yu MX; Lei B; Song X; Huang YM; Ma XQ; Hao CX; Yang WH; Pan ML
J Ethnopharmacol; 2021 Mar; 268():113560. PubMed ID: 33161027
[TBL] [Abstract][Full Text] [Related]
4. Molecular Targets and Mechanisms of
Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
[TBL] [Abstract][Full Text] [Related]
5. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
[TBL] [Abstract][Full Text] [Related]
6. Uncovering the protective mechanism of Taohong Siwu decoction against diabetic retinopathy via HIF-1 signaling pathway based on network analysis and experimental validation.
Wang L; Li S; Wang L; Lin K; Du J; Miao W; Zhang L
BMC Complement Med Ther; 2020 Oct; 20(1):298. PubMed ID: 33023593
[TBL] [Abstract][Full Text] [Related]
7. Systematic investigation of
Kang T; Qin X; Chen Y; Yang Q
World J Diabetes; 2024 May; 15(5):945-957. PubMed ID: 38766429
[TBL] [Abstract][Full Text] [Related]
8. Network Pharmacology Combined with Bioinformatics to Investigate the Mechanisms and Molecular Targets of
Zhao J; Mo C; Shi W; Meng L; Ai J
Evid Based Complement Alternat Med; 2021; 2021():9980981. PubMed ID: 34349833
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology].
Zhang XW; Liu AM; Zhao JJ; Guo J; Chen XY; Qu XX
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):894-901. PubMed ID: 33645094
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.
Yu Y; Yang F; Liu H
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33196098
[TBL] [Abstract][Full Text] [Related]
11. Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy.
Yao H; Xin D; Zhan Z; Li Z
Evid Based Complement Alternat Med; 2021; 2021():6642600. PubMed ID: 33747106
[TBL] [Abstract][Full Text] [Related]
12. Exploring the molecular mechanism of Xuebifang in the treatment of diabetic peripheral neuropathy based on bioinformatics and network pharmacology.
Hu F; Lin J; Xiong L; Li Z; Liu WK; Zheng YJ
Front Endocrinol (Lausanne); 2024; 15():1275816. PubMed ID: 38390212
[TBL] [Abstract][Full Text] [Related]
13. Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach.
Ma X; Yu M; Hao C; Yang W
Evid Based Complement Alternat Med; 2020; 2020():1027271. PubMed ID: 32025234
[TBL] [Abstract][Full Text] [Related]
14. Systematic Elucidation of the Mechanism of
Kang X; Jin D; Zhang Y; Zhou R; Zhang Y; Lian F
Evid Based Complement Alternat Med; 2021; 2021():5528018. PubMed ID: 34306139
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology-based prediction of the active ingredients and mechanism of Shen Gui capsule for application to coronary heart disease.
Wang D; Tian L; Shi C; Wei YX; Wang H; Liu TT; Gong M; Zhang YW; Yu RG; Wu XH
Comput Biol Med; 2020 Jul; 122():103825. PubMed ID: 32658730
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Key Active Ingredients and Anti-Inflammatory and Analgesic Effects of Shenjin Huoxue Mixture Against Osteoarthritis by Integrating Network Pharmacology Approach and Thin-Layer Chromatography Analysis.
Yu MX; Ma XQ; Song X; Huang YM; Jiang HT; Wang J; Yang WH
Drug Des Devel Ther; 2020; 14():1145-1156. PubMed ID: 32214800
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the Potential Mechanisms of Lingqihuangban Granule for Treating Diabetic Retinopathy Based on Network Pharmacology.
He S; Gu C; Su T; Zhou C; Lhamo T; Draga D; Yin L; Qiu Q
Comb Chem High Throughput Screen; 2023; 26(1):14-29. PubMed ID: 35392781
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Mechanism of Action Compound-Xueshuantong Capsule in Diabetic Retinopathy Treatment Based on Network Pharmacology.
Li H; Li B; Zheng Y
Evid Based Complement Alternat Med; 2020; 2020():8467046. PubMed ID: 32963574
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of Alisma orientale in treating nonalcoholic fatty liver disease].
Jiang-Dong D; Chuan-Yan L; Bing Y; Yue W; Li C; Liang F; Xiao-Bin J
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4140-4148. PubMed ID: 33164398
[TBL] [Abstract][Full Text] [Related]
20. Molecular network-based analysis of guizhi-shaoyao-zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy.
Zhao N; Li J; Li L; Niu XY; Jiang M; He XJ; Bian ZX; Zhang G; Lu AP
Acta Pharmacol Sin; 2015 Jun; 36(6):716-23. PubMed ID: 25948477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
